Literature DB >> 16741470

Dislocation of the hip after reimplantation for infection: an analysis of risk factors.

Curtis W Hartman1, Kevin L Garvin.   

Abstract

Dislocation is a well documented complication after a two-stage revision arthroplasty for a deep periprosthetic hip infection. We are aware of no reports specifically evaluating the risk factors for dislocation after reimplantation for infection. We hypothesized greater age, increase in the number of operations on the hip, increase in the length of time from resection to reimplantation, greater limb length discrepancy, smaller femoral offset, and using smaller femoral heads would increase the risk of dislocation. We retrospectively reviewed 34 patients who had a two-stage hip revision for periprosthetic infection with a minimum followup of 2 years. Risk factors for dislocation were evaluated. We compared the rate of dislocation in this group to those patients having revision for aseptic failure. Sixteen dislocations occurred in five (14.7%) of 34 patients. Dislocation occurred in three (1.7%) of 171 patients having revision for aseptic failure. In this small series, age at reimplantation, number of previous operations on the hip, length of time from resection to reimplantation, limb length discrepancy, femoral offset, and femoral head size did not seem to be risk factors for dislocation.

Entities:  

Mesh:

Year:  2006        PMID: 16741470     DOI: 10.1097/01.blo.0000218747.92118.3a

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  3 in total

1.  [Hip joint infections - Results of a questionnaire among 28 university orthopedic departments].

Authors:  K Anagnostakos; D Kohn
Journal:  Orthopade       Date:  2011-09       Impact factor: 1.087

2.  Pelvic support osteotomy in the treatment of patients with excision arthroplasty.

Authors:  Khaled Mohamed Emara
Journal:  Clin Orthop Relat Res       Date:  2008-02-10       Impact factor: 4.176

3.  Complications after spacer implantation in the treatment of hip joint infections.

Authors:  Jochen Jung; Nora Verena Schmid; Jens Kelm; Eduard Schmitt; Konstantinos Anagnostakos
Journal:  Int J Med Sci       Date:  2009-09-02       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.